PRESS RELEASE published on 02/07/2025 at 15:37, 1 year 7 months ago Franchissement de seuil Déclaration de franchissement de seuil par BlackRock Inc. pour ARKEMA avec une détention de 4,99% du capital et 3,99% des droits de vote Capital Droits De Vote Franchissement De Seuil BlackRock Inc. ARKEMA
BRIEF published on 02/03/2025 at 14:36, 1 year 7 months ago Arkema Announces Update on Shares and Voting Rights Voting Rights French Commercial Code Shares Financial Markets Authority ARKEMA
BRIEF published on 02/03/2025 at 14:36, 1 year 7 months ago Arkema annonce une mise à jour de son actionnariat et de ses droits de vote Autorité Des Marchés Financiers Actions Droit De Vote Code De Commerce Français ARKEMA
PRESS RELEASE published on 02/03/2025 at 14:31, 1 year 7 months ago Inside Information / Other news releases Correction made to the total number of voting rights as per regulatory requirements. Details provided in compliance with L.233-8 II of the French commercial code and 223-16 of the AMF Voting Rights French Commercial Code AMF Regulatory Requirements Correction
PRESS RELEASE published on 02/03/2025 at 14:31, 1 year 7 months ago Informations privilégiées / Autres communiqués Déclaration du nombre réel de droits de vote et d'actions d'une entreprise suite à une rectification. Communication réglementée conformément au Code de commerce et à la réglementation de l'AMF Déclaration Droits De Vote Code De Commerce Actions AMF
BRIEF published on 02/03/2025 at 10:08, 1 year 7 months ago Franchissement de seuil par BlackRock dans le capital d'Arkema Capital Droits De Vote Franchissement De Seuil BlackRock ARKEMA
BRIEF published on 02/03/2025 at 10:08, 1 year 7 months ago BlackRock Crosses Threshold in Arkema Capital Voting Rights Capital BlackRock Threshold Crossing ARKEMA
PRESS RELEASE published on 02/03/2025 at 10:03, 1 year 7 months ago Franchissement de seuil Déclaration de franchissement de seuil par BlackRock Inc. pour le compte de clients et fonds de 3 588 661 actions ARKEMA, représentant 4,72% du capital et 3,77% des droits de vote Déclaration Franchissement De Seuil Bourse BlackRock Inc. ARKEMA
BRIEF published on 01/28/2025 at 14:19, 1 year 7 months ago Arkema Discloses Share Buyback Transactions Share Buyback Financial Management Stock Market EU Regulation ARKEMA
BRIEF published on 01/28/2025 at 14:19, 1 year 7 months ago Arkema dévoile des opérations de rachat d'actions Rachat D'actions Bourse Gestion Financière ARKEMA Règlement De L'UE
Published on 09/11/2026 at 04:00, 7 hours 50 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 13 hours 25 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 20 hours 30 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 20 hours 50 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 11:43, 7 minutes ago Skyborn reaches Financial Close on the Gennaker offshore wind farm project
Published on 09/11/2026 at 11:35, 15 minutes ago EQS-Adhoc: Correction of a release from 10/09/2026, 19:35 CET/CEST - United Internet AG: Group subsidiaries 1&1 AG and IONOS Group SE launch transformation programs
Published on 09/11/2026 at 11:30, 20 minutes ago Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress
Published on 09/11/2026 at 10:15, 1 hour 35 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 07:00, 4 hours 50 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 4 hours 50 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 4 hours 50 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 16 hours 20 minutes ago Availability of the 2026 Interim Financial Report
